Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Critical Reviews in Oncology/Hematology
|
October 1, 2013
Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation
Maria Gkotzamanidou, Christos A Papadimitriou
International Journal of Molecular Sciences
|
October 13, 2021
Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy
Maria Gkotzamanidou, Elisavet Terpou, Nikolaos Kentepozidis, et al.
International Journal of Molecular Sciences
|
December 23, 2022
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma
Maria Gkotzamanidou, Evangelos Terpos, Meletios A Dimopoulos, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 21, 2013
Angiogenic cytokines profile in smoldering multiple myeloma: no difference compared to MGUS but altered compared to symptomatic myeloma
Maria Gkotzamanidou, Dimitrios Christoulas, Vasillis L Souliotis, et al.
Expert Opinion on Therapeutic Targets
|
July 6, 2012
Sclerostin: a possible target for the management of cancer-induced bone disease
Maria Gkotzamanidou, Meletios A Dimopoulos, Efstathios Kastritis, et al.
Expert Opinion on Therapeutic Targets
|
June 18, 2009
Dickkopf-1: a suitable target for the management of myeloma bone disease
Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Dimitrios Christoulas, et al.
Blood
|
July 23, 2016
DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
Maria Gkotzamanidou, Evangelos Terpos, Christina Bamia, et al.
Leukemia & Lymphoma
|
December 7, 2011
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens
Evangelos Eleftherakis-Papapiakovou, Esftathios Kastritis, Maria Roussou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients
Evangelos Terpos, Anna Tasidou, Evangelos Eleftherakis-Papaiakovou, et al.
European Journal of Haematology
|
June 3, 2011
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy
Magdalini Migkou, Efstathios Kastritis, Maria Roussou, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Critical Reviews in Oncology/Hematology
|
October 1, 2013
Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation
Maria Gkotzamanidou, Christos A Papadimitriou
International Journal of Molecular Sciences
|
October 13, 2021
Targeting the Interplay between HDACs and DNA Damage Repair for Myeloma Therapy
Maria Gkotzamanidou, Elisavet Terpou, Nikolaos Kentepozidis, et al.
International Journal of Molecular Sciences
|
December 23, 2022
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma
Maria Gkotzamanidou, Evangelos Terpos, Meletios A Dimopoulos, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 21, 2013
Angiogenic cytokines profile in smoldering multiple myeloma: no difference compared to MGUS but altered compared to symptomatic myeloma
Maria Gkotzamanidou, Dimitrios Christoulas, Vasillis L Souliotis, et al.
Expert Opinion on Therapeutic Targets
|
July 6, 2012
Sclerostin: a possible target for the management of cancer-induced bone disease
Maria Gkotzamanidou, Meletios A Dimopoulos, Efstathios Kastritis, et al.
Expert Opinion on Therapeutic Targets
|
June 18, 2009
Dickkopf-1: a suitable target for the management of myeloma bone disease
Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Dimitrios Christoulas, et al.
Blood
|
July 23, 2016
DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7
Maria Gkotzamanidou, Evangelos Terpos, Christina Bamia, et al.
Leukemia & Lymphoma
|
December 7, 2011
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens
Evangelos Eleftherakis-Papapiakovou, Esftathios Kastritis, Maria Roussou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients
Evangelos Terpos, Anna Tasidou, Evangelos Eleftherakis-Papaiakovou, et al.
European Journal of Haematology
|
June 3, 2011
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy
Magdalini Migkou, Efstathios Kastritis, Maria Roussou, et al.
Page
of 3